One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
Existing-Home Sales Flounder for Over Three Years, What’s Going On?
-
Sales have gone nowhere for over 3 years. Median price keeps rising.
14 minutes ago
No comments:
Post a Comment